A unique opportunity for global leaders in Fragile X research to gather, network and share ideas.

Barcelona, Spain

November 7-8, 2004

  • Diagnosis and newborn screening
  • Holistic care for infants, teens and adults
  • Medical therapies and outcome
  • measures
  • FXPAC: FXTAS, FXPOI and other FMR1
  • premutation-associated issues
  • Mosaicism and biomarkers
  • in FXS and FXPAC
  • The future of Fragile X

This website is automatically translated using AI. If you spot a translation error, please contact us.